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● The genus Streptomyces accounts for 
producing 80% of antibiotics in use today 
(Procopio et al., 2012). The discovery and 
production of antibiotics is imperative to 
keep up with the ever-growing strains of 
drug-resistant pathogens.
● According to the Centers for Disease 
Control and Prevention, a US citizen is 
infected by an antibiotic-resistant pathogen 
every 11 seconds, every 15 minutes a 
patient dies as a result (CDC, 2019).
● With this project, I intend to explore and 
analyze antibiotic-producing Streptomyces 
species from soil in Spokane County, WA.
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1. To test the efficacy of secondary 
metabolites from local Streptomyces 
species, I will adjust variables to 
determine what environmental conditions 
(e.g. temperature) and media types will 
influence the best metabolite production. 
2. Specifically, I will test metabolites that will 
combat ESKAPE pathogens 
(Enterococcus faecium, Staphylococcus 
aureus, Klebsiella pneumoniae, 
Acinetobacter baumanni, Pseudomonas 
aeruginosa, and Enterobacter species) 
and Candida albicans, which are 
common nosocomial pathogenic bacteria 
and fungi with drug-resistant strains.
3. After the efficacy of secondary 
metabolites have been examined, future 






Gram-stained Streptomyces hyphae from Medical Lake, WA.
1) Obtain soil sample and determine 
colony-forming units (CFUs) by 
suspending the sample in phosphate 
buffered saline (PBS) (Reynolds, 2005). 
Dilutions of 10⁻¹, 10⁻², 10⁻³, and 10⁻⁴ will be 
incubated on potato dextrose agar (PDA) 
serial dilution plates at 30℃ for at least 48 
hours.
2) CFUs will be examined and colonies of 
interest will be selected and placed on a 
master plate (thick-poured PDA) and 
incubated again at 30℃ for at least 48 
hours.Colonies will be selected based on 
macroscopic observations of known 
Streptomyces spp. morphology. Additional 
identification will include Gram-staining 
acid-fastness, and microscopic 
morphology from isolated colonies (Taddei 
et al., 2006).
3) Cell-free supernatants (CFS) will be 
obtained from cultured Streptomyces sp. in 
broth media (sabouraud dextrose broth, 
yeast dextrose broth, potato dextrose 
broth) at 25, 30, and 35℃ (Bell et al., 
2015). Flow-through containing CFS will be 
used to saturate disks using the 
Kirby-Bauer technique and zones of 
inhibition will be analyzed against 
pathogens.
4) CFS will be used again to fill 96-well 
plate assays. Fifty ul of CFS will be 
combined with 50ul of one of each of the 
selected ESKAPE pathogens (E. coli for 
gram negative, S. aureus for gram positive 
and C. albicans for the fungi). 
Figure 2.
An example of a completed master plate.
Figure 1
Figure 2.
K. Kramer, preliminary data.
1) Streptomyces spp. capable of 
combating pathogenic microbes exist in 
Spokane County soil.
2) Modifying laboratory variables such as 
incubation time, temperature, and media 
type will influence the production of 
bacterial metabolites.
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Using the Top-Layer Overlay assay (not included) one 
can visualize the inhibitory capabilities of an isolated 
colony of Streptomyces sp.. In this assay, selected 
microbes were grown on a medium and an overlay of 
agar inoculated with S. aureus was poured, and zones of 
inhibition measured (K. Kramer, preliminary data).
Fifteen replicate wells for each treatment 
will be included with each assay and 
positive controls will be present as well 
as media-only control. Microplates will be 
checked every 24 hours for three days 
and absorbance measured at 600 nm 
using a spectrophotometer.
5) To identify the Streptomyces spp., I 
will amplify the 16S rRNA gene using 
polymerase chain reaction (PCR) and 
verified using gel electrophoresis, 
followed by Sanger sequencing of the 
16S rRNA gene and BLAST analysis 
with the National Center for 
Biotechnology Information (NCBI) 
database. 
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